Kazazian Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,530	Closed	-$359K	–	76
2018 Q3	$359K	Hold	12,530	–	–	0.34%	55
2018 Q2	$343K	Buy	12,530 +2,773	+28%	+$75.9K	0.31%	64
2018 Q1	$206K	Buy	+9,757	New	+$206K	0.22%	73